Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitor
- 1 December 1991
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 181 (3) , 1070-1076
- https://doi.org/10.1016/0006-291x(91)92046-m
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education
This publication has 14 references indexed in Scilit:
- Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parentPublished by Elsevier ,2004
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- Inhibition of angiogenesis by vitamin D3 analoguesEuropean Journal of Pharmacology, 1990
- Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related PeptidesScience, 1990
- A highly potent antiangiogenic activity of retinoidsCancer Letters, 1989
- Leukotriene C4 stimulates angiogenesis in bovine carotid artery endothelial cells in vitroBiochemical and Biophysical Research Communications, 1989
- Angiogenic activity of rat mammary carcinomas induced by 7, 12-dimethylbenz[a]anthracene and its inhibition by medroxyprogesterone acetate: possible involvement of antiangiogenic action of medroxyprogesterone acetate in its tumor growth inhibitionCancer Letters, 1988
- Angiogenic FactorsScience, 1987
- Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of CortisoneScience, 1983
- Protamine is an inhibitor of angiogenesisNature, 1982